Dol­lars flow with three new pub­lic of­fer­ings, two pri­vate place­ments

A hand­ful of biotechs an­nounced plans to raise mon­ey this week.

First up is Hookipa Phar­ma, which an­nounced Wednes­day night that it is look­ing to raise $50 mil­lion in gross earn­ings in a pub­lic of­fer­ing — by sell­ing 22.9 mil­lion shares of com­mon stock at $1.31 a share. The biotech, which is de­vel­op­ing im­muno-on­col­o­gy treat­ments and in­fec­tious dis­ease pro­grams, is al­so of­fer­ing rough­ly 15,000 shares of non-vot­ing pre­ferred stock, which could be con­vert­ed in­to 1,000 shares of com­mon stock for a price of $1,310 each.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.